The launch of BetterLix comes at a critical time for liver patients. In last few decades, fatty liver disease has become an epidemic in the U.S. with now over 100 million Americans being affected by liver conditions, mostly fatty liver disease or also called metabolic dysfunction-associated fatty liver disease (MAFLD).